Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.
A Manitoba urologist is returning to Carberry to open a medical clinic in mid-January to perform prostate cancer screenings ...
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.
Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...
Men’s Health Thailand by Dr. Niti Navanimitkul For many men, a diagnosis of prostate cancer comes with two major worries: ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Global Biopsy Devices Market OverviewThe global biopsy devices market is expected to expand at a steady growth rate of 7% over the next five years, supported by rising cancer prevalence, increasing ...
Committee rejects routine screening The UK National Screening Committee advised against routine screening for prostate cancer with the prostate specific antigen (PSA) blood test, arguing that the ...
CUPid is what is known as a 'liquid biopsy' - blood tests that look for tiny fragments of cancer DNA in the blood. Developed at The Christie and the University of Manchester, this technique is so ...
IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...
The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results